RSS   Newsletter   Contact   Advertise with us

RxGenomix appoints Blake Keller as chief operating officer

Staff Writer | Franklin, Tenn., USA | March 13, 2019
Blake KellerBlake Keller has joined RxGenomix, a biotechnology company, as chief operating officer.
Mr. Keller has served in various clinical, operational, and business development capacities over his professional career.

Mr. Keller most recently served as President, North America of Fagron, a leading pharmaceutical compounding company active in 35 countries worldwide.

Previously, he served as Vice President of Premise Health, the largest direct onsite and near-site comprehensive healthcare provider, serving hundreds of Fortune 1000 firms.

For many years, Mr. Keller has taught Doctor of Pharmacy students in advanced practice settings, developing future clinical leaders.

Mr. Keller also spent 12 years as a staff pharmacist, pharmacy manager, and healthcare supervisor with Walgreens Boots Alliance, the first global, pharmacy-led, health and well-being enterprise.